LCMS webinars focusing on OMICS - page 3

Part 3 of the Chemoproteomics Master Class highlights activity-based proteome profiling and covalent screening to accelerate target identification and drug discovery using scalable MS workflows.

Part 2 of the Chemoproteomics Master Class explores HT-PELSA with Orbitrap Astral MS, showing peptide-level ligand binding analysis for target discovery, specificity, and drug pipeline insights.

In this first master class session, explore how advanced mass spectrometry strategies are powering the next generation of drug discovery through chemoproteomics.

Combining chromatography, trapped ion mobility, accurate mass and fragment information enables confident discovery and annotation of novel lipids in this key model organism.

Join this webinar to hear about latest methods and advances for probing intact protein complexes in tissue using in situ native mass spectrometry.

Discover how next-generation LC–MS and the ZenoTOF 8600 enable robust, high-throughput LFQ proteomics, backed by insights from a large multi-laboratory benchmark study.

Join us to learn how scalable proteomics workflows are moving from promise to practice.

Learn how PASEF-based MS and real-time bioinformatics reveal structural glycan features for biomarker discovery and translational research.

Learn how to design robust metabolomics studies—from defining biological questions to selecting targeted or untargeted methods, minimizing bias, and ensuring high-quality, reproducible data.

Explore how spatial multiomics combining MALDI Imaging, proteomics, transcriptomics, and HiPLEX-IHC reveals new tumor subpopulations linked to chemoresistance and survival in ovarian cancer.